Page last updated: 2024-08-26

arsenic and Hematologic Malignancies

arsenic has been researched along with Hematologic Malignancies in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's22 (70.97)29.6817
2010's7 (22.58)24.3611
2020's2 (6.45)2.80

Authors

AuthorsStudies
Bunce, CM; Drayson, MT; Khanim, FL1
Al Ustwani, O; Griffiths, EA; Torka, P; Wang, ES; Wetzler, M1
Falchi, L; Kantarjian, HM; Ravandi-Kashani, F; Verstovsek, S1
Colombo, M; Diaz, Z; Komarnitsky, PB; Kourelis, M; Mann, KK; Marcoux, S; Miller, WH1
Chan, GC; Sze, DM1
Gotlib, J; Oh, ST1
Fan, LP; Fu, HY; Shen, JZ; Shen, SF; Wu, Y; Zhou, HR1
Hu, XM; Liu, F; Ma, R1
Takahashi, S1
Shen, Q; Tang, YH1
Han, ZC; Liu, P1
Dutcher, JP; Garl, S; Lucariello, R; Unnikrishnan, D; Varshneya, N; Wiernik, PH1
Evens, AM; Gartenhaus, RB; Tallman, MS1
Estrov, Z; Verstovsek, S1
Kwong, YL1
Sekeres, MA1
Douer, D; Tallman, MS1
Amadori, S; Fenaux, P; Ludwig, H; O'dwyer, M; Sanz, M1
Boehrer, S; Chow, KU; Hoelzer, D; Mitrou, PS; Nowak, D1
Beran, M; Freireich, E; Giles, F; Kantarjian, H; Perez, N; Quintás-Cardama, A; Ravandi-Kashani, F; Verstovsek, S1
Bonati, A; Lunghi, P; Rizzoli, V1
Augustyniak, C; Evens, AM; Gordon, LI; Gupta, R; Mehta, J; Ziegler, SL1
Au, WY; Fong, BM; Kwong, YL; Tam, S; Wan, TS; Yip, SF1
Novick, SC; Warrell, RP1
Murgo, AJ1
Tallman, MS1
Chen, G; Huang, Y; Zhu, Q1
Bloomfield, CD; Slack, JL; Tallman, MS; Tricot, G; Waxman, S1
Miller, WH; Waxman, S1
Cheng, YY; Guo, HR; Li, CY; Lin, MH1
Bandopadhyay, D; Chakraborty, T; Chaudhuri, U; De, M; Halder, A; Paul, S1

Reviews

20 review(s) available for arsenic and Hematologic Malignancies

ArticleYear
Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignancies.
    Blood cancer journal, 2022, 10-07, Volume: 12, Issue:10

    Topics: Arsenic Trioxide; Arsenicals; Hematologic Neoplasms; Humans; Leukemia, Promyelocytic, Acute; Oxides; Thalidomide; Translational Research, Biomedical; Tretinoin

2022
Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.
    Blood reviews, 2016, Volume: 30, Issue:3

    Topics: Administration, Intravenous; Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Hematologic Neoplasms; Humans; Leukemia, Promyelocytic, Acute; Oxides; Remission Induction; Treatment Outcome

2016
The evolution of arsenic in the treatment of acute promyelocytic leukemia and other myeloid neoplasms: Moving toward an effective oral, outpatient therapy.
    Cancer, 2016, Apr-15, Volume: 122, Issue:8

    Topics: Administration, Oral; Ambulatory Care; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Clinical Trials, Phase III as Topic; Female; Follow-Up Studies; Forecasting; Hematologic Neoplasms; Humans; Infusions, Intravenous; Leukemia, Promyelocytic, Acute; Male; Oxides; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome

2016
Supplements for immune enhancement in hematologic malignancies.
    Hematology. American Society of Hematology. Education Program, 2009

    Topics: Adult; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; beta-Glucans; Child; Clinical Trials as Topic; Dietary Supplements; Digestive System Neoplasms; Drug Screening Assays, Antitumor; Drug Synergism; Drugs, Chinese Herbal; Ganoderma; Hematologic Neoplasms; Herb-Drug Interactions; Humans; Immunologic Factors; Mice; Oxides; Phytotherapy; Plant Preparations; Polyporus; Thalidomide

2009
Combination therapy with arsenic trioxide for hematological malignancies.
    Anti-cancer agents in medicinal chemistry, 2010, Volume: 10, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Hematologic Neoplasms; Humans; Oxides

2010
[Molecular mechanism of malignant hematological tumor cell apoptosis induction by active components of traditional Chinese herbs].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2010, Volume: 30, Issue:7

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Diterpenes; Drugs, Chinese Herbal; Epoxy Compounds; Hematologic Neoplasms; Humans; Oxides; Phenanthrenes; Quercetin; Tumor Cells, Cultured

2010
Treatment of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide: review of clinical and basic studies.
    International journal of hematology, 2003, Volume: 78, Issue:1

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Hematologic Neoplasms; Humans; Leukemia, Promyelocytic, Acute; Oxides

2003
The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future.
    Leukemia research, 2004, Volume: 28, Issue:9

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Hematologic Neoplasms; Humans; Oxidation-Reduction; Oxides

2004
Arsenic derivatives as therapeutic agents for hematologic malignancies.
    Leukemia research, 2004, Volume: 28, Issue:9

    Topics: Administration, Oral; Antineoplastic Agents; Arsenicals; Hematologic Neoplasms; Humans

2004
Arsenic trioxide in the treatment of haematological malignancies.
    Expert opinion on drug safety, 2004, Volume: 3, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Drug Resistance, Neoplasm; Hematologic Neoplasms; Humans; Oxides; Remission Induction; Salvage Therapy; Tretinoin

2004
Arsenic trioxide as a treatment for myelodysplastic syndrome.
    Current hematology reports, 2005, Volume: 4, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Cell Division; Clinical Trials as Topic; Dexamethasone; DNA-Binding Proteins; Drug Therapy, Combination; Glutathione; Hematologic Neoplasms; Humans; Leukemia, Promyelocytic, Acute; MDS1 and EVI1 Complex Locus Protein; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxides; Proto-Oncogenes; Transcription Factors

2005
Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-01, Volume: 23, Issue:10

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Hematologic Neoplasms; Humans; Oxides

2005
Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent.
    Current medical research and opinion, 2005, Volume: 21, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Drug Design; Hematologic Neoplasms; Humans; Mitochondria; Oxides; Polymerase Chain Reaction; Prognosis

2005
Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies.
    Current pharmaceutical design, 2006, Volume: 12, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzamides; Drug Resistance, Neoplasm; Enzyme Inhibitors; Hematologic Neoplasms; Histone Deacetylase Inhibitors; Humans; Imatinib Mesylate; Oligonucleotides, Antisense; Oxides; Piperazines; Proteasome Endopeptidase Complex; Pyrimidines; Rituximab; Thalidomide

2006
Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?
    Hematological oncology, 2006, Volume: 24, Issue:4

    Topics: Administration, Oral; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Disease-Free Survival; Hematologic Neoplasms; Humans; Leukemia, Promyelocytic, Acute; Oxides; Remission Induction; Treatment Outcome

2006
Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug.
    Current pharmaceutical biotechnology, 2006, Volume: 7, Issue:6

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Hematologic Neoplasms; Humans; Multiple Myeloma; Oxides; Practice Patterns, Physicians'; Treatment Outcome

2006
Arsenicals in hematologic cancers.
    Seminars in oncology, 2000, Volume: 27, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Hematologic Neoplasms; Humans; Leukemia, Promyelocytic, Acute; Oxides; Tumor Cells, Cultured

2000
Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies.
    The oncologist, 2001, Volume: 6 Suppl 2

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Hematologic Neoplasms; Humans; National Institutes of Health (U.S.); Oxides; United States

2001
Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies.
    Blood reviews, 2001, Volume: 15, Issue:3

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Hematologic Neoplasms; Humans; Leukemia, Promyelocytic, Acute; Oxides; Survival Analysis

2001
Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide.
    The oncologist, 2002, Volume: 7 Suppl 1

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Hematologic Neoplasms; Humans; Leukemia, Promyelocytic, Acute; Multiple Myeloma; Myelodysplastic Syndromes; Oxides; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome; Tretinoin

2002

Trials

1 trial(s) available for arsenic and Hematologic Malignancies

ArticleYear
Cardiac monitoring of patients receiving arsenic trioxide therapy.
    British journal of haematology, 2004, Volume: 124, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Arrhythmias, Cardiac; Arsenic Trioxide; Arsenicals; Edema; Electrocardiography, Ambulatory; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Oxides; Prospective Studies

2004

Other Studies

10 other study(ies) available for arsenic and Hematologic Malignancies

ArticleYear
A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.
    Leukemia, 2008, Volume: 22, Issue:10

    Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Resistance, Neoplasm; Glutathione; Hematologic Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mice; Multidrug Resistance-Associated Proteins; Oncogene Proteins, Fusion; Oxidative Stress; Oxides

2008
Antiangiogenic therapy in myelodysplastic syndromes: is there a role?
    Current hematologic malignancy reports, 2008, Volume: 3, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arsenic Trioxide; Arsenicals; Bevacizumab; Clinical Trials as Topic; Drug Approval; Farnesyltranstransferase; Hematologic Neoplasms; Humans; Lenalidomide; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxides; Protein-Tyrosine Kinases; Thalidomide

2008
Arsenic trioxide inhibits DNA methyltransferase and restores expression of methylation-silenced CDKN2B/CDKN2A genes in human hematologic malignant cells.
    Oncology reports, 2010, Volume: 24, Issue:2

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cyclin-Dependent Kinase Inhibitor p15; DNA Methylation; DNA Modification Methylases; Drug Evaluation, Preclinical; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, p16; Hematologic Neoplasms; Humans; Oxides; Promoter Regions, Genetic; Tumor Cells, Cultured; U937 Cells

2010
Application and assessment of Chinese arsenic drugs in treating malignant hematopathy in China.
    Chinese journal of integrative medicine, 2010, Volume: 16, Issue:4

    Topics: Arsenic Trioxide; Arsenicals; China; Drugs, Chinese Herbal; Hematologic Neoplasms; Humans; Oxides

2010
Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/lymphoma.
    Clinical lymphoma & myeloma, 2007, Volume: 7, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow Transplantation; Central Nervous System Neoplasms; Diphtheria Toxin; Drug Resistance, Neoplasm; Hematologic Neoplasms; Humans; Interferons; Interleukin-2; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Recombinant Fusion Proteins; Recurrence; Remission Induction; Transplantation, Homologous; Zidovudine

2007
Second hematological malignancies during arsenic trioxide therapy of B-cell lymphomas.
    Leukemia research, 2009, Volume: 33, Issue:1

    Topics: Aged; Arsenic Trioxide; Arsenicals; Female; Hematologic Neoplasms; Humans; Lymphoma, B-Cell; Male; Neoplasms, Second Primary; Oxides

2009
[The relationship between sensitivity to arsenic trioxide and antioxidative capacity of malignant hematopoietic cells].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2000, Volume: 22, Issue:5

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Survival; Glutathione Peroxidase; Glutathione Transferase; Hematologic Neoplasms; HL-60 Cells; Humans; K562 Cells; Oxides; Superoxide Dismutase; Tumor Cells, Cultured; U937 Cells

2000
Differentiation induction as a treatment for hematologic malignancies.
    Oncogene, 2002, May-13, Volume: 21, Issue:21

    Topics: Arsenic Trioxide; Arsenicals; Cell Differentiation; Hematologic Neoplasms; Leukemia, Promyelocytic, Acute; Models, Biological; Oncogene Proteins, Fusion; Oxides; Signal Transduction; Transcription, Genetic

2002
Arsenic in Drinking Water and Incidences of Leukemia and Lymphoma: Implication for Its Dual Effects in Carcinogenicity.
    Frontiers in public health, 2022, Volume: 10

    Topics: Arsenic; Carcinogenesis; Drinking Water; Female; Hematologic Neoplasms; Humans; Incidence; Leukemia; Lymphoma; Male; Neoplasms

2022
Association of genotoxic effects of arsenic with haematological malignancy in West Bengal.
    Human & experimental toxicology, 2011, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Arsenic; Child; Chromosome Aberrations; Female; Hair; Hematologic Neoplasms; Humans; India; Male; Middle Aged; Mutagens; Nails; Retrospective Studies; Water Pollutants, Chemical; Young Adult

2011